Busy. Please wait.
or

show password
Forgot Password?

Don't have an account?  Sign up 
or

Username is available taken
show password

why


Make sure to remember your password. If you forget it there is no way for StudyStack to send you a reset link. You would need to create a new account.
We do not share your email address with others. It is only used to allow you to reset your password. For details read our Privacy Policy and Terms of Service.


Already a StudyStack user? Log In

Reset Password
Enter the associated with your account, and we'll email you a link to reset your password.

Remove Ads
Don't know
Know
remaining cards
Save
0:01
To flip the current card, click it or press the Spacebar key.  To move the current card to one of the three colored boxes, click on the box.  You may also press the UP ARROW key to move the card to the "Know" box, the DOWN ARROW key to move the card to the "Don't know" box, or the RIGHT ARROW key to move the card to the Remaining box.  You may also click on the card displayed in any of the three boxes to bring that card back to the center.

Pass complete!

"Know" box contains:
Time elapsed:
Retries:
restart all cards




share
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.

  Normal Size     Small Size show me how

FLREMS

Finger Lakes Medications

QuestionAnswer
Activated Charcoal - Classification Cathartic/GI Absorbent
Activated Charcoal - Action Binds toxic substances there by inhibiting GI absorption, enterohepatic circulation, and bioavailability.
Activated Charcoal - Indications Ingested Poisions/Overdose
Activated Charcoal - Contraindications AMS, inability to protect airway. Ineffective for alkali poisonings, cyanide, ethanol, iron, lithium, methanol, mineral acids, and organic solvents. Alcohol
Activated Charcoal - Adverse Effects Vomiting, stoll discoloration, diarrhea, abdominal cramping and gloating, and constipation
Activated Charcoal - Dosage/Route Adult: 50g PO Peds: 1g/kg up to 50g PO
Adenosine (Adenocard) - Classification Antidysrhythmic, Endogenous Nucleoside
Adenosine (Adenocard) - Action Slows conduction time through AV node, Interrupts re-entry pathways through AV and SA Nodes, "Chemical Valsalva"
Adenosine (Adenocard) - Indications SVT - stable and unstable, PSVT associated with WPW, Undifferentiated wide complex tachycardia
Adenosine (Adenocard) - Contraindications Ineffective for A-Fib/A-Flutter but maybe useful in identifying these conditions, Inhibited by methylxanthines (theophylline, caffeine), 2 degree/3 degree heart blocks, Sick sinus syndrome, Symptomic bradycardia, Poison/drug-ingested tachycardia
Adenosine (Adenocard) - Adverse Effects Transient arrhythmias, chest pain, dizziness/light headedness Facial flushing, H/A, sweating, palpitations, hypotension, SOB, nausea
Adenosine (Adenocard) - Dosage/Route Adult: 6mg initial rapid IVP, repeat 12mg rapid IVP times 2 Peds: 0.1mg/kg up to 6mg rapid IVP, repeat 0.2mg/kg up to 12mg rapid IVP
Albuterol (Proventil, Ventolin) - Classification Beta-2 sympathomimetic, Adrenergic agonist
Albuterol (Proventil, Ventolin) - Action Bronchodilation; Relaxation of bronchial tree smooth muscle decreasing airway resistance, facilitating mucus drainage, and increase vital capacity; Inhibits histamine release from mast cells thus reducing mucus secretion, capillary leaking, muscosal edema
Albuterol (Proventil, Ventolin) - Indications Bronchoconstriction related to obstructive pulmonary disease or lower respiratory infection, Asthma, Reversible bronchospasm with COPD, Allergic reactions
Albuterol (Proventil, Ventolin) - Contraindications Ineffective ventilation requiring BVM assistance, unless NEB can be placed in circuit without interference; symptomatic tachycardia; known hypersensitivity
Albuterol (Proventil, Ventolin) - Adverse Reactions Tremor/Anxiety, tachycardia, palpitations, H/A, sweating, seizures, HTN, paradoxical bronchospasm
Albuterol (Proventil, Ventolin) - Dosage/Route Adult: 2.5 - 5mg NEB Peds: 1.25 - 2.5mg NEB
Amiodarone (Cardarone) - Classification Antiarrhythmic (Class III - potassium channel blocker)
Amiodarone (Cardarone) - Action Prolong duration of the action potential and refractory period without significantly affecting the resting membrane potential; relaxes peripheral vascular resistance; increase coronary blood flow; blocks effects of sympathetic stimulation
Amiodarone (Cardarone) - Indications Ventricular arrhythmias, VF/Pulseless VT, stable wide complex tachycardia; stable narrow complex tachycardia refactory to Adenosine, Diltiazem, or Metoprolol; post-conversion of VF/Pulseless VT
Amiodarone (Cardarone) - Contraindications Cardiogenic shock, bradycardia, hypotension, 2 degree/3 degree HB, ventricular escape/idioventricular rhythms
Amiodarone (Cardarone) - Adverse Reactions Hypotension, bradycardia, HB, dizziness H/A, sinus arrest, cardiogenic shock, N/V, Torsade de pointes, CHF, cyanosis, Asystole, ARDS
Amiodarone (Cardarone) - Dosage/Route Cardiac Arrest: Adult: 300mg diluted in 20ml NS, IVP; Peds: 5mg/kg up to 300mg diluted in 20 NS, IVP;Other uses: Adult: 150mg diluted in 50-100ml NS infused over 15 minutes; Peds: 5mg/kg up to 150mg diluted in 50-100ml NS infused over 15 minutes
Aspirin - Classification NSAID/Anticoagulant Analgesic, platelet inhibitor
Aspirin - Action Blocks formation of thromboxane A2 which causes platelet aggregation and arterial constriction
Aspirin - Indications ACS, cardiac chest pain
Aspirin - Contraindications Allergy/Hypersensitivity, active bleeding, asthma
Aspirin - Adverse Reactions Nausea, GI discomfort, N/V/D, heartburn, dizziness, thrombocytopenia, hemolytic anemia
Aspirin - Dosage/Route Adult: 324mg PO, chewed PEDS: None
Atropine - Classification Parasympatholytic/Anticholinergic
Atropine - Action Competitive anatgonist that selectively blocks all muscarinic responses to ACh, blocks vagal impulses to the heart that increases SA NODS discharge, enhances conduction through AV junction, increases CO, increases myocardial oxygen demand; antisecretory a
Atropine - Indications Hemodynamically significant bradycardia, cholinesterase inhibitor poisoning from nerve agents or organophosphate insecticides
Atropine - Contraindications Glaucoma, benign prostate hypertrophy, A-Fib/A-Flutter, active MI (relative contraindications), tachycardia, 2 degree Type 2 or 3 degree HB at His-Purkinje level
Atropine - Adverse Effects Tachycardia (VT, AF, VF, palpitations), dilated pupils, drying mucus membranes, flushing of skin, N/V, H/A, HTN or hypotension
Atropine - Dosage/Route Bradycardia-Adult: 0.5mg rapid IVP (max dose of 0.4mg/kg or 3mg) Peds: 0.02mg/kg (up to 1mg) rapid IVP Poisonings-Adult/Peds: 1mg IVP repeated until signs of atropinization appear (dryness of mucus membranes, skin flushing, pupillary dilation, tachyca
Calcium Chloride/Gluconate - Classification Electrolyte
Calcium Chloride/Gluconate - Action Acts as an activator in transmission of nerve impulses and contraction of cardiac, skeletal, and smooth muscle; useful in reversing cardiac arrhythmia e due to hyperkalemia; maintains cell membrane and capillary permeability
Calcium Chloride/Gluconate - Indications Suspected hyperkalemia, hypocalcemia, calcium channel overdose; Abdominal muscle spasm associated with spider bite and Portuguese man-o-war stings
Calcium Chloride/Gluconate - Contraindications Digitalis use, hypercalcemia, VF, renal calculus
Calcium Chloride/Gluconate - Adverse Effects Bradycardia, syncope, Asystole, hypotension, coma Warning: do not mix with/administer together with sodium bacarbonate, will produce insoluble precipitate
Calcium Chloride/Gluconate - Dosage/Route Adult: 1g slow IVP Peds: 20mg/kg up to 1g slow IVP
Dexamethasone - Classification Steroid
Dexamethasone - Action Decrease inflammation by suppression of migration of PMN leukocytes, fibroblasts, reversal of increased capillary permeability and lysosomal stabilization
Dexamethasone - Indications Adrenal insufficiency
Dexamethasone - Contraindications Systemic infections, psychosis, idiopathic thrombocytopenia, amebiasis, fungal infections, non-asthmatic bronchial disease, children under 2 years old, AIDS, TB
Dexamethasone - Adverse Effects Steroid psychosis, depression, flushing, sweating. HTN, circulatory collapse, thrombophlebitis, embolism, N/V/D, abdominal distention. GI hemorrhage, increase appetite, pancreatitis, thrombocytopenia
Dexamethasone - Dosage/Route Adult: 4mg IVP Peds: 0.3mg/kg up to 4mg IVP
Dextrose 12.5%, 25%, 50% - Classification Hypoglycemic, Carbohydrate
Dextrose 12.5%, 25%, 50% - Action Provides principle glucose used by body to create energy
Dextrose 12.5%, 25%, 50% - Indications Hypoglycemia
Dextrose 12.5%, 25%, 50% - Contraindications None
Dextrose 12.5%, 25%, 50% - Adverse Effects Tissue necrosis in event of extravasation; pain and burning at injection site
Dextrose 12.5%, 25%, 50% - Dosage/Route Adult: 50ml 50% solution, slow IVP Peds: less than 1 month: 4ml/kg 12.5% solution 1 month - 2 years: 2ml/kg 25% solution 6 years or greater: 1ml/kg 50% solution up to 50ml
Diltiazem (Cardizem) - Classification Anti arrhythmic (Class IV - calcium channel blocker)
Diltiazem (Cardizem) - Action Inhibits calcium ion influx through slow channels into myocardial cells and arterial smooth muscle thus reducing cell excitation & contraction, slows AV & SA Node conduction without affecting normal action potential/intraventricular conduction
Diltiazem (Cardizem) - Indications SVT, A-Fib/A-Flutter refractory to Adenosine, PSVT refractory to Adenosine
Diltiazem (Cardizem) - Contraindications Hypotension, 2 degree/3 degree HB, bradycardia, heart failure, Wolff-Parkinson White with A-Fib, cardiogenic shock, sick sinus syndrome, VT, poision/drug-induced tachycardias
Diltiazem (Cardizem) - Adverse Effects Hypotension, AV heart block, bradycardia, H/A, dizziness, CHF, flushing, N/V
Diltiazem (Cardizem) - Dosage/Route Adult: 15 - 20mg slow IVP
Diphenhydramine (Benadryl) - Classification Antihistamine (H1 antagonist)
Diphenhydramine (Benadryl) - Action Binds to histamine receptor sites to prevent further allergic reaction, causes sedation, causes anticholinergic effect
Diphenhydramine (Benadryl) - Indications Allergic reactions, Anaphylactic shock, medication-related dystonia
Diphenhydramine (Benadryl) - Contraindications None
Diphenhydramine (Benadryl) - Adverse Effects Drowsiness, paradoxical excitement in children, drying/thickening of bronchial secretions, dry mouth, hypotension; seizures, coma, death (toxic)
Diphenhydramine (Benadryl) - Dosage/Route Adult: 50mg IM/IVP Peds: 1mg/kg up to 50mg IM/IVP
Dopamine (Intropin) - Classification Sympathomimetic/Adrenergic Agonist Natural Catecholamine
Dopamine (Intropin) - Acton Low Dose: Selectively dilates blood vessels supplying brain, kidneys, heart, & GI tract; Medium Dose: Increases CO (beta), contractility (inotropic), SV, BP; High Dose: Causes vasoconstriction (alpha), heart rate (chronotropic)
Dopamine (Intropin) - Indications Non-hypovolemic hypotension, hemodynamically significant bradycardia, cardiogenic shock
Dopamine (Intropin) - Contraindications Tachycardia, HTN, hypovolemic shock, acute MI (relative), pheochromocytoma, VF
Dopamine (Intropin) - Adverse Effects Tachycardia or palpitations, HTN or hypotension, chest pain, increase myocardial oxygen, ventricular irritability
Dopamine (Intropin) - Dosage/Route Adult/Peds: 5 - 20mcg/kg IV infusion titrated to effect (use of IV flow regulating/limiting device is required. Ex. Dial-A-Drip)
Epinephrine - Classification Sympathomimetic/Adrenergic Agent Natural Catecholamine
Epinephrine - Action B1 = Increases SBP, HR, CO B2 = Dilate bronchial smooth muscle, inhibit mucus secretion Alpha = Bronchoconstriction, inhibit histamine release, arterioconstriction
Epinephrine - Indications Cardiac arrest, Anaphylatic shock, hemodynamically significant bradycardia, Bronchoconstriction from asthma or COPD exacerbation
Epinephrine - Contraindications None in cardiac arrest/anaphylactic shock, do not give through same IV as bicarbonate 1:1000 - cardiovascular disease, HTN, pregnancy, tachyarrhythmias 1:10,000 - narrow-angle glaucoma; hemorrhagic, traumatic, or cardiogenic shock
Epinephrine - Adverse Effects Tachycardia, HTN, chest pain, anxiety/tremor, increase myocardial oxygen requirements, H/A, N/V
Epinephrine - Dosage/Route Cardiac Arrest: Adult: 1mg 1:10,000 IVP Peds: 0.01 mg/kg 1:10,000 (up to 1 mg) IVP; Anaphylactic Shock: Adult: 0.3mg 1:1000 IM, Peds: 0.01mg/kg 1:1000 (up to 0.3mg) IM; Bradycardia: Adult: 2-10mcg IV infusion titrated to effect; Bronchoconstriction: Adult
Epinephrine Auto-Injector (Epi-pen) - Classification Sympathomimetic/Adrenergic Agonist
Epinephrine Auto-Injector (Epi-pen) - Action B1: strengthen myocardial contraction; increases SBP, HR, CO B2: dilate bronchial smooth muscle, inhibit mucus secretion Alpha: Bronchoconstriction, inhibit histamine release, arterioconstriction
Epinephrine Auto-Injector (Epi-pen) - Indications Anaphylactic shock with respiratory/circulatory shock
Epinephrine Auto-Injector (Epi-pen) - Contraindications None
Epinephrine Auto-Injector (Epi-pen) - Adverse Effects Tachycardia, HTN, chest pain, anxiety/tremor, increases myocardial requirements
Epinephrine Auto- Injector (Epi-pen) - Dosage/Route Adult: 0.3mg IM Peds: 0.15mg IM
Etomidate (Amidate) - Classification Hypnotic/Sedative
Etomidate (Amidate) - Action Produces rapid induction of anesthesia
Etomidate (Amidate) - Indications Sedation for rapid sequence intubation (RSI)
Etomidate (Amidate) - Contraindications Hypersensitivity, Adrenal insufficiency
Etomidate (Amidate) - Adverse Effects Adrenal insufficiency, hypotension, myoclonic skeletal muscle movements, apnea, eye movements, nausea
Etomidate (Amidate) - Dosage/Route Adult: 0.3mg/kg IVP (up to 40mg)
Fentanyl - Classification Opiate analgesic
Fentanyl - Action Inhibits ascending pain pathways in CNS, increases pain threshold
Fentanyl - Indications Moderate to severe pain
Fentanyl - Contraindications Respiratory depression, hypersensitivity, myasthenia gravis
Fentanyl - Adverse Effects Respiratory depression, sedation, respiratory arrest, laryngospasm, bradycardia, cardiac arrest, hypotension/HTN, miosis
Fentanyl - Dosage/Route Adult: 25 - 50mcg IVP Peds: 1mcg/kg (up to 25mcg) IVP
Furosemide (Lasix) - Classification Loop diuretic
Furosemide (Lasix) - Action Rapid-acting potent sulfonamide loop diuretic and antihypertensive, Inhibits reabsorption of NA and CL primarily in Loop of Henle thus increasing excretion of water and ions, reduces cardiac preload through vasodilation thus decreasing cardiac workload
Furosemide (Lasix) - Indications Acute pulmonary edema, CHF
Furosemide (Lasix) - Contraindications Allergy to sulfa drugs, pregnancy, dehydration, hypovolemia, hypokalemia
Furosemide (Lasix) - Adverse Effects Hypotension, hypokalemia, postural hypotension, dizziness, dehydration, N/V, tinnitus (feeling of fullness in ears), hyperglycemia, increase sweating, blurred vision
Furosemide (Lasix) - Dosage/Route Adult: 20 - 80mg IVP
Glucagon - Classification Endogenous hormone, polypeptide
Glucagon - Action Converts stored glycogen to glucose, inhibits synthesis of glycogen from glucose, increases heart rate and myocardial contractility, improves AV conduction
Glucagon - Indications Hypoglycemia without IV access, beta blocker overdose
Glucagon - Contraindications Hypersensitivity, ineffective in states of starvation/absent glycogen stores in liver
Glucagon - Adverse Effects N/V, tachycardia, HTN, dizziness, H/A, hypotension, hyperglycemia, hypokalemia
Glucagon - Dosage/Route Adult: 1mg IM Peds: 0.1mg/kg up to 1mg IM
Glucose Gel/Tablets (Instant Glucose)- Classification Hyperglycemic
Glucose Gel/Tablet (Instant Glucose) - Action Increase blood sugar
Glucose Gel/Tablet (Instant Glucose) - Indications Hypoglycemia
Glucose Gel/Tablet (Instant Glucose) - Contraindications AMS without inability to protect airway
Glucose Gel/Tablet (Instant Glucose) - Adverse Effects None
Glucose Gel/Tablet (Instant Glucose) - Dosage/Route Adults & Peds: 15g buccal or sublingual
Haloperidol (Haldol) - Classification Neuroleptic, antipsychotic, major tranquilizer
Haloperidol (Haldol) - Action Blocks dopamine receptors in brain responsible for mood & behavior; depresses cerebral cortex, hypothalamus, limbic system which control activity & aggression; exhibits strong alpha-adrenergic, anticholingeric blocking action; has antiemetic properties
Haloperidol (Haldol) - Indications Combativeness associated with behavioral emergencies/psychosis
Haloperidol (Haldol) - Contraindications CNS depression, non-psychosis related dementia, Parkinson's disease, presence of other sedatives, angina, epilepsy, narrow-angle glaucoma, children under 3 years old
Haloperidol (Haldol) - Adverse Effects Dystonia/extrapyramidal reaction, drowsiness, respiratory depression, seizures, tachycardia, dry mouth, N/V, H/A
Haloperidol (Haldol) - Dosage/Route Adult: 2.5 - 10mg IVP
Ipratropium (Atrovent) - Classification Parasympatholytic bronchodilator, anticholinergic
Ipratropium (Atrovent) - Action Acts directly on bronchial tree smooth muscle by inhibiting ACh @ receptor sites resulting in bronchodilation & decrease secretions; abolishes vagally mediated reflex bronchospasm by inhaled irritants & inflammatory mediators
Ipratropium (Atrovent) - Indications Bronchoconstriction from asthma and COPD
Ipratropium (Atrovent)- Contraindication Hypersensitivity to atropine, glaucoma, tachycardia, benign prostate hypertrophy (BRH)
Ipratropium (Atrovent) - Adverse Effects Tachycardia, dry mouth, blurred vision, nausea, H/A, bitter taste, exacerbation of symptoms
Ipratropium (Atrovent) - Dosage/Route Adult: 0.5mg Neb (must be used in combination with albuterol)
Ketamine (Ketalar, Class III)- Classification Hypnotic, sedative
Ketamine (Ketalar, Class III) - Action Non-competitive antagonism of glutamate @ NMDA receptor, interacts with morphine receptors
Katamine (Ketalar, Class III) - Indications Procedural sedation, behavioral/psychiatric emergencies
Katamine (Ketalar, Class III) - Contraindications HTN, stroke, head trauma, increase ICP, cardiac decompensation
Katamine (Ketalar, Class III) - Adverse Effects Hypotension, bradycardia, dystonia/extrapyramidal reactions, increase salivary/bronchial secretions
Ketamine (Ketalar, Class III) - Doasge/Route Adult: 5mg/kg IV
Lidocaine (Xylocaine) - Classification Antiarrhythmic Class Ib - sodium channel blocker
Lidocaine (Xylocaine) - Action Suppresses automaticity in His-Purkinje system, elevates electrical stimulation threshold of ventricle during diastole, lowers threshold for defibrillation and cardioversion
Lidocaine (Xylocaine) - Indications Ventricular arrhythmias (VF/VT), post conversion of VF/VT, RSI premedication
Lidocaine (Xylocaine) - Contraindications Hypotension, 2/3 degree HB, idioventricular rhythm, bradycardia, hypersensitivity to amide-type anesthetics, Strokes-Adams syndrome
Lidocaine (Xylocaine) - Adverse Effects Seizures, paresthesias, decrease HR, dizziness, light-headedness, irritability; numbness of tongue & lips; difficulty breathing/swallowing; muscular twitching tremors
Lidocaine (Xylocaine) - Dosage/Route Cardiac Arrest: Adult/Peds: 1-1.5mg/kg IVP Pre RSI w/ head injury: 1mg/kg IVP Other: Adult/Peds: 0.5-0.75mg/kg IVP followed by IV infusion per med control
Lidocaine (Xylocaine) - Drip Rate in 1g/250cc 1mg/min = 15gtts/min 2mg/min = 30gtts/min 3mg/min = 45gtts/min 4mg/min = 60gtts/min
Lorazepam (Ativan)Class IV - Classification Benzodiazepine, sedative, hypnotic, skeletal muscle relaxant
Lorazepam (Ativan) Class IV - Action Mediated by inhibitory neurotransmitter GABA, suppresses spread of seizure activity through motor cortex, amnestic effects
Lorazepam (Ativan) Class IV - Indications Seizures, procedural sedation, behavioral/psychiatric emergencies
Lorazepam (Ativan) Class IV - Contraindications Respiratory depression, alcohol intoxication, pregnancy/nursing moms
Lorazepam (Ativan) Class IV - Adverse Effects Respiratory depression, amnesia, drowsiness, confusion, HTN or hypotension, hallucinations, weakness
Lorazepam (Ativan) Class IV - Dosage/Route Adult: 1-2mg IV/IM Peds: 0.1mg IV/IM (up to 2mg)
Magnesium Sulfate - Classification Smooth muscle relaxant, electrolyte
Magnesium Sulfate - Action Physiologic calcium channel blocker and blocks neuromuscular transmission, CNS depressant; depresses smooth, skeletal, & cardiac muscle function; decrease amount of ACh
Magnesium Sulfate - Indications Refractory VF/VT, Torsades de pointes, toxemia/eclamptic seizures, bronchoconstriction due to asthma, hypomagnesemia
Magnesium Sulfate - Contraindications Hypotension, renal disease, hypocalcemia, heart block, shock, persistent HTN
Magnesium Sulfate - Adverse Effects Hypotension, CNS depression, confusion, muscle weakness, depressed reflexes, flushing, complete HB
Magnesium Sulfate - Dosage/Route Cardiac Arrest: Adult: 1-2g IVP Peds: 25-50mg/kg Other: Adult: 1-2g diluted in 50-100ml NS infused of 15-20 minutes Peds: 25-50mg/kg (max 2g) infused over 15-20 minutes
Methylprednisolone (Solu-Medrol) - Classification Corticosteroid
Methlyprednisolone (Solu-Medrol) - Action Decrease inflammation by suppression of migration of PMN leukocytes and fibroblasts, reversal of increase capillary permeability and lysosomal stabiliztion
Methlyprednisolone (Solu-Medrol) - Indications Status asthmaticus, severe anaphylactic shock, adrenal insufficiency
Methlyprednisolone (Solu-Medrol) - Contraindications Known hypersensitivity, psychosis, thrombocytopenia, acute glomerulonephritis, amebiasis, non-asthmatic bronchial disease, AIDS, TB, fungal infections, children under 2 years old
Methlyprednisolone (Solu-Medrol) - Adverse Effects N/V, hyperglycemia
Methlyprednisolone (Solu-Medrol) - Dosage/Route Adult: 125mg IV Peds: 1mg/kg up to 125mg IV
Metoprolol (Lopressor) - Classification Sympatholytic/Beta antagonist, antiarrhythmic
Metoprolol (Lopressor) - Action Selectively blocks B2-adrenergic receptors, lowers BP by B-blocking effects
Metoprolol (Lopressor) - Indications SVT, narrow complex tachycardias, MAT, PAT, PSVT, A-Fib
Metoprolol (Lopressor) - Contraindications CHF, 2/3 degree HB, cardiogenic shock, hypotension, bradycardia, suspected recent cocaine use, asthma
Metoprolol (Lopressor) - Adverse Effects Hypotenstion, bradycardia, bronchospasm, CHF, palpitations
Metoprolol (Lopressor) - Dosage/Route Adult: 5mg slow IVP repeat every 5 minutes to 15 max PRN
Midazolam (Versed) Class IV - Classification Benzodiazepine, Sedative
Midazolam (Versed) Class IV - Action Relaxes skeletal muscles by intensifying activity of GABA (gamma-aminobenzoic acid)
Midazolam (Versed) Class IV - Indications Seizures, procedural sedation, behavioral/psychiatric emergencies, post-intubation sedation
Midazolam (Versed) Class IV - Contraindications Respiratory depression, hypotension, alcohol intoxication, glaucoma, shock
Midazolam (Versed) Class IV - Adverse Effects Respiratory depression, hypotension, amnesia, H/A, confusion, nystagmus, pinpoint pupils
Midazolam (Versed) Class IV - Dosage/Route Adult/Peds: 0.1mg/kg up to 4mg IV/IM
Morphine Sulfate Class II - Classification Opiate analgesic, CNS depressant
Morphine Sulfate Class II - Action Ads on opiate receptors in brain to produce analgesia & sedation, causes vasodilation which increases peripheral venous capacitance & reduces venous return, reduces cardiac workload & decrease myocardial oxygen demand, thus reducing infarct size, relaxes
Morphine Sulfate Class II - Indications Pain, cardiac chest pain, CHF, non-cardiac pain management
Morphine Sulfate Class II - Contraindications Hypotension, respiratory depression, N/V, undiagnosed head injury/acute abdomen, shock, pulmonary diseases, chemically induced pulmonary edema
Morphine Sulfate Class II - Adverse Effects Respiratory depression, hypotension, N/V
Morphine Sulfate Class II - Dosage/Route Adult: 1-5mg IV/IM repeat PRN Peds: 0.1mg/kg up to 5mg IV/IM
Naloxone (Narcan) - Classification Opiate antagonist
Naloxone (Narcan) - Action Competes for and displaces narcotic molecules from opiate receptors in the brain
Naloxone (Narcan) - Indications Actual or suspected opiate overdose
Naloxone (Narcan) - Contraindications Opiate habituation (relative)
Naloxone (Narcan) - Adverse Effects N/V, opiate withdrawal, increase BP, hyperventilation, sweating, tachycardia
Naloxone (Narcan) - Dosage/Route Adult: 0.4-2mg IV/IM/Intranasal Peds: 0.1mg/kg up to 2mg IV/IM/Intranasal
Nitroglycerine (Nitrostat, Nitro-Bid) - Classification Nitrate
Nitroglycerine (Noitrostat, Nitro-Bid) - Action Relaxes vascular smooth muscle, promotes peripheral pooling of blood, reduction of peripheral resistance, decrease venous return to the heart, decrease left ventricular preload & afterload, decrease myocardial oxygen demand
Nitroglycerine (Nitrostat, Nitro-Bid) - Indications Acute coronary syndromes, chest pain, acute CHF, pulmonary edema
Nitroglycerine (Nitrostat, Nitro-Bid) - Contraindications Hypotension, head injury, right sided MI (relative), bradycardia, use of erectile dysfunction meds in last 48 hours, severe anemia, glaucoma, shock
Nitroglycerine (Notrostat, Nitro0Bid) - Adverse Effects H/A, flushing, hypotension, dizziness, dry mouth, postural hypotension, palpitations, paradoxical bradycardia, syncope
Ondansetron (Zofran) - Classification Antiemetic
Ondansetron (Zofran) - Action Selectively antagonizes serotonin 5-HT3 receptors
Ondansetron (Zofran) - Indications Nausea, vomiting
Ondansetron (Zofran) - Contraindications Hypersensitivity, patients under 40kg
Ondansetron (Zofran) - Adverse Effects Respiratory depression, hypotension, QT prolongation, Anaphylaxis, bronchospasms, extrapyramidal symptoms, blurred vision or temporary blindness, fever, slow HR, trouble breathing, anxiety, drowsiness, light-headed, weakness
Ondansetron (Zofran) - Dosage/Route Adult: 4mg IV
Oxygen - Classification Elemental gas
Oxygen - Action Binds with hemoglobin to travel to cells
Oxygen - Indications Respiratory distress, actual/suspected tissue hypoxia, shock, ACS, CVA/stroke
Oxygen - Contraindications None
Oxygen - Adverse Effects Respiratory depression in COPD patients
Oxygen - Dosage/Route Adults: 2-6 lpm NC or 10-15 lpm NRB Peds: 10-15 lpm NRB or blow by
Promethazine (Phenergan) - Classification Antihistamine (H1 agonist), antiemetic
Promethazine (Phenergan) - Action Mild anticholingeric activity, antiemetic, potentiates actions of vomiting
Promethazine (Phenergan) - Indications N/V, motion sickness, to potentiate effect of analgesics
Promethazine (Phenergan) - Contraindications Patients under 2 years old, caution with head injury, coma, acute asthma attack, lower respiratory tract disease, patients who have received large amounts of depressants
Promethazine (Phenergan) - Adverse Effects AMS, respiratory depression, tissue necrosis (dilute in 20mg NS), drownsiness, dizziness
Promethazine (Phenergan) - Dosage/Route Adult: 6.25-12.5mg IV
Sodium Bicarbonate - Classification Alkalinizing agent, electrolyte
Sodium Bicarbonate - Action Raises pH of blood plasma by buffering excess hydrogen ions (acidosis)
Sodium Bicarbonate - Indications Metabolic acidosis, selected drug overdose (Tricyclic anti-depressants, barbiturate), suspected hyperkalemia with rhythm changes, prolonged arrest
Sodium Bicarbonate - Contraindications Respiratory acidosis/inability to ventilate
Sodium Bicarbonate - Adverse Effects Iatrogenic metabolic alkalosis, don't administer through same IV as epinephrine/dopamine (inactivates catecholamines), don't administer together with calcium chloride, will produce insoluble precipitate
Sodium Bicarbonate - Dosage/Route Adult/Peds: 1mEq/kg IV
Succinylcholine (Anectine, Quelecin) - Classification Deplorizing neuromuscular blocking agent
Succinylcholine (Anetine, Quelecin) - Action Combines with cholinergic receptors of the motor end plate to produce depolarization thus inhibiting subsequent neuromuscular transmission
Succinylcholine (Anetine, Quelecin) - Indications Induction of paralysis for rapid sequence intubation (RSI)
Succinylcholine (Anetine, Quelecin) - Contraindications Hyperkalemia, renal failure, burn/crush injury greater than 24 hours, degenerative neuromuscular disease, obvious facial/neck deformities which indicate inability to intubate, malignant hyperthermia, glaucoma, penetrating eye injuries
Succinylcholine (Anetine, Quelecin) - Adverse Effects Hyperkalemia, malignant hyperthermia, fasciculations, bradycardia/tachycardia, hypotension/HTN, dysrhythmias, excessive salivation, increase ICP, increase IOP, increase gastric pressure
Succinylcholine (Anetine, Quelecin) - Dosage/Route Adult: 1-2mg/kg IV/IM
Vasopressin - Classification Endogenous hormone, vasopressor
Vasopressin - Action Increase peripheral vascular resistance
Vasopressin - Indications Cardiac arrest, VF/pulseless VT
Vasopressin - Contraindications None
Vasopressin - Adverse Effects HTN, fluid retention, tremor, sweating, vertigo, abdominal cramps/has, N/V, drowsiness/light-headedness, H/A, seizures, coma
Vasopressin - Dosage/Route 40 units IV
Vecuronium - Classification Non-depolarizing neuromuscular blocking agent
Vecuronium - Action Inhibits transmission of nerve impulses by binding with cholinergic receptor sites, antagonizing action of acetycholine
Vecuronium - Indications Maintenance of paralysis following rapid sequence intubation (RSI)
Vecuronium - Contraindications Airway not secured with intubation/supraglottic airway
Vecuronium - Adverse Effects Hypersensitivity, respiratory apnea
Vecuronium - Dosage/Route Adult: 0.1mg/kg up to 10mg IV
Created by: abryantatc